BioNTech (BNTX)
(Delayed Data from NSDQ)
$124.71 USD
+1.24 (1.00%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $125.01 +0.30 (0.24%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
BioNTech SE Sponsored ADR (BNTX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$110.71 | $171.00 | $85.00 | -10.33% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for BioNTech SE Sponsored ADR comes to $110.71. The forecasts range from a low of $85.00 to a high of $171.00. The average price target represents a decline of 10.33% from the last closing price of $123.47.
Analyst Price Targets (14)
Broker Rating
BioNTech SE Sponsored ADR currently has an average brokerage recommendation (ABR) of 2.07 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 2.20 a month ago based on 15 recommendations.
Of the 15 recommendations deriving the current ABR, seven are Strong Buy, representing 46.67% of all recommendations. A month ago, Strong Buy represented 46.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 8 | 7 | 7 | 9 | 9 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 1 | 1 | 1 | 1 |
ABR | 2.07 | 2.20 | 2.20 | 2.47 | 2.47 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/6/2024 | Goldman Sachs | Chris Shibutani | Hold | Hold |
8/6/2024 | Cowen & Co. | Yaron Werber | Hold | Hold |
8/6/2024 | Not Identified | Not Identified | Hold | Hold |
8/6/2024 | UBS | Eliana Merle | Hold | Hold |
8/2/2024 | Not Identified | Not Identified | Hold | Strong Buy |
8/1/2024 | H.C. Wainwright & Co. | Robert Burns | Strong Buy | Strong Buy |
7/29/2024 | Not Identified | Not Identified | Hold | Hold |
5/14/2024 | Evercore Partners | Cory Kasimov | Not Available | Hold |
4/16/2024 | SVB Securities | Daina M Graybosch | Strong Buy | Strong Buy |
3/21/2024 | BMO Capital Markets | Etzer Darout | Strong Buy | Strong Buy |
3/21/2024 | Canaccord Genuity | William Maughan | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.07 |
ABR (Last week) | 2.20 |
# of Recs in ABR | 15 |
Average Target Price | $110.71 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -0.99 |
BNTX FAQs
BioNTech SE Sponsored ADR (BNTX) currently has an average brokerage recommendation (ABR) of 2.07 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms.
The average price target for BioNTech SE Sponsored ADR (BNTX) is $110.71. The current on short-term price targets is based on 9 reports.
The forecasts for BioNTech SE Sponsored ADR (BNTX) range from a low of $85 to a high of $171. The average price target represents a decline of $11.23 from the last closing price of $124.71.
The current DOWNSIDE for BioNTech SE Sponsored ADR (BNTX) is 11.23%
Based on short-term price targets offered by 14 analysts, the average price target for BioNTech SE Sponsored ADR comes to $110.71. The forecasts range from a low of $85.00 to a high of $171.00. The average price target represents a decline of 10.33% from the last closing price of $123.47.